SEC Form 4 · accession 0001209191-16-153325
INTEGRA LIFESCIENCES HOLDINGS CORP · IART
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert T. Davis Jr.
Officer — CVP,PRES-ORTHO & TISSUE TECH
Period of report
Dec 1, 2016
Accepted (ET)
Dec 5, 2016 · 4:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000917520
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F1 | $76.85 | Dec 1, 2016 | A | 8,705 | A | — | Dec 1, 2024 | Common Stock | 8,705 | 8,705 | D |
Explanation of responses
- F1100% of the shares of stock options will vest on the third anniversary of the grant date of 12/01/2016.